# Single-Time Gastroscopy in High-Risk Patients: Screening Effectiveness for Gastric Precancerous Conditions in a Low-To Moderate-Incidence Population

**Authors:** Krystian Ciechański, Erwin Ciechański, Krystyna Kłosowska-Kapica, Barbara Skrzydło-Radomańska

PMC · DOI: 10.3390/jcm14196910 · Journal of Clinical Medicine · 2025-09-29

## TL;DR

A single high-quality gastroscopy can help identify early signs of gastric cancer in high-risk patients, but biopsies are still needed for accurate detection.

## Contribution

The study evaluates the effectiveness of single-time gastroscopy in detecting gastric precancerous conditions in a low-to-moderate incidence population.

## Key findings

- Single high-quality endoscopy has low sensitivity for detecting advanced gastric precancerous conditions.
- Males are at higher risk for extensive intestinal metaplasia.
- Family history of gastric cancer is associated with lower OLGA/OLGIM stages.

## Abstract

Background: Gastric cancer (GC) is the fifth most common malignancy worldwide. Early detection of precancerous conditions—atrophic gastritis (AG), intestinal metaplasia (IM), and dysplasia—is vital for surveillance. Objectives: To assess the accuracy of single high-quality endoscopy (HQE) in detecting advanced GPCs and to identify risk factors for AG, IM, and dysplasia. Methods: A retrospective review of 442 gastroscopies (2017–2022) at a single center. Endoscopic findings were compared with histology, including OLGA/OLGIM staging, dysplasia, and Helicobacter pylori (H. pylori) status. Results: The study population comprised 319 women (72.17%) and 123 men (27.83%), with a mean age of 59 years (SD: 12.53). AG, as defined by OLGA and OLGIM staging, was identified in 90 patients (20.36%) and 50 patients (11.31%), respectively. A total of 44 cases of de novo gastric dysplasia were observed, while HP infection was confirmed in 37 individuals (8.37%). We observed similar low sensitivity for detection of advanced OLGA (32.5%), OLGIM (40%), and dysplasia (19.7%) with relatively high specificity (~89%). Advanced AG and IM peaked at ages 51–53. Risk factors for advanced OLGIM included male sex (OR 2.26; p < 0.001) and presence of dysplasia (OR 2.09; p = 0.02). Dysplasia was positively associated with AG (OR 2.03; p < 0.001) and IM (OR 2.21; p < 0.001) but inversely associated with a family history of GC (OR 0.44; p < 0.001). Conclusions: A single HQE can help exclude advanced GPCs, but due to low sensitivity, gastric mapping biopsies remain crucial. Males are at increased risk of extensive IM. Family history of GC was linked to lower OLGA/OLGIM stages.

## Linked entities

- **Diseases:** gastric cancer (MONDO:0001056), atrophic gastritis (MONDO:0006665), intestinal metaplasia (MONDO:0100190)

## Full-text entities

- **Diseases:** GC (MESH:D013274), Dysplasia (MESH:D015792), AG (MESH:D005757), Gastric Precancerous Conditions (MESH:D011230), IM (MESH:D007410), malignancy (MESH:D009369), gastric dysplasia (MESH:D013272), HP infection (MESH:C537262)
- **Species:** Homo sapiens (human, species) [taxon 9606], Helicobacter pylori (species) [taxon 210]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12524409/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12524409/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC12524409/full.md

---
Source: https://tomesphere.com/paper/PMC12524409